Editorial Comment

J Urol. 2020 Sep;204(3):449. doi: 10.1097/JU.0000000000001023.01. Epub 2020 Jun 23.
No abstract available

Publication types

  • Comment

MeSH terms

  • BCG Vaccine*
  • Cost-Benefit Analysis
  • Humans
  • Urinary Bladder Neoplasms*

Substances

  • BCG Vaccine